Wells Fargo lifts Elevance Health target to USD 492
Alpha Vantage · ad-hoc-news.de · · AI-summarised by FinFlash
Wells Fargo raised its Elevance Health price target to USD 492 from USD 473, keeping an Overweight rating on constructive Medicaid and health exchange trends. The bank also lifted earnings estimates through 2028, with its 2026 EPS estimate of USD 30.28 running 4.5% above consensus. The move follows stronger-than-expected third-quarter revenue and adjusted earnings.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.